- Global Pharma News & Resources

Global End Stage Renal Disease Market is expected to grow at a CAGR of 12.4% during the forecast period 2020-2027

A new research report published by Fior Markets with the title End Stage Renal Disease Market By Type Of Treatment (Transplantation And Dialysis), End-User Applications (Dialysis Centres, Hospital & Clinics, And Research And Academic Institutes), Region, Global Industry Analysis, Market Size, Share, Growth, Trends, And Forecast 2020 To 2027.

The Global End Stage Renal Disease Market is expected to grow from USD 68.00 billion in 2019 to USD 173.23 billion by 2027, at a CAGR of 12.4% during the forecast period 2020-2027. Asia-Pacific accounts for the largest market share in this market. This is primarily because of the increasing number of kidney patients, technological innovation, favourable government initiatives and policies, the introduction of efficient and advanced technology equipments in the region. In addition to that this region has a large number of diabetic and hypertension patients which are the most common causes of this disease, this will fuel the growth of this market in the region. Also, the Asia-Pacific region is anticipated to witness the highest growth rate in future. The hectic lifestyle in urban cities, ageing population, increasing patient affordability, and improvement in the quality of diagnosis are the factors responsible for the growth of this market. Middle East & Africa is expected to grow at the second-highest growth rate, owing to the incidence rate of CKD is 18-23% of the total population, which is much higher than the global population.

NOTE: Our analysts monitoring the situation across the globe explains that the market will generate remunerative prospects for producers post COVID-19 crisis. The report aims to provide an additional illustration of the latest scenario, economic slowdown, and COVID-19 impact on the overall industry.


Some of the key players in the end stage renal disease market are Fresenius Medical Care AG & Co. KGaA, Nipro Corporation, Medtronic Plc, Baxter International, Inc., Asahi Kasei Medical Co., Ltd., B. Braun Melsungen AG, Nikkiso Co., Ltd, JMS Co. Ltd. and Cantel Medical.

By the type of treatment, the market is broadly bifurcated into transplantation and dialysis. The dialysis segment further includes peritoneal dialysis, hemodialysis, and wearable artificial kidney. The dialysis segment dominates this segment because it is more convenient and easy for a patient with end stage kidney disease as the whole process can be done at home or dialysis centre. Also, patients in low-income or developing economies can only obtain this process as compared to transplantation, and patients don’t have to be completely dependent upon donor organs, which are very limitedly available as compared to dialysis equipment. Within the dialysis segment, the hemodialysis segment holds the largest market share. By the type of end-user application, the market is segmented into dialysis centres, hospital & clinics, and research and academic institutes.

In October 2019, Fresenius Medical Care received a breakthrough device designation by the FDA (US) for its new hemodialysis machine. The machine aims to prevent blood clotting without the use of any medication. Moreover, other leading market players are introducing technologically advanced products and equipments to have a competitive advantage over others.


About the report:
The global End Stage Renal Disease market is analyzed on the basis of value (USD Billion), volume (K Units), export (K Units), and import (K Units). All the segments have been analyzed on global, regional and country basis. The study includes an analysis of more than 30 countries for each segment. The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The study includes porter’s five forces model, attractiveness analysis, raw material analysis, and competitor position grid analysis.

Customization of the Report:
The report can be customized as per client requirements. For further queries, you can contact us on or +1-201-465-4211. Our executives will be pleased to understand your requirements and offer you the best-suited reports.

Contact Us
Mark Stone
Phone: +1-201-465-4211

This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 28-Jul-2020